Cerus Tops Q1 EPS by 2c
- ByInvesting.com-
Cerus (NASDAQ:CERS) reported Q1 EPS of ($0.07), $0.02 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $43 million versus the consensus estimate of...
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Cerus Corporation (CERS)
NASDAQ
Symbol | Exchange | Currency |
|---|
5.230
-0.020(-0.38%)
After Hours
5.140
-0.090(-1.721%)
- Real-time Data
- Volume:1,310,871
- Day's Range:5.140 - 5.290
- 52 wk Range:4.345 - 8.055
CERS Overview
- Prev. Close
- 5.25
- Day's Range
- 5.14-5.29
- Revenue
- 172.97M
- Open
- 5.26
- 52 wk Range
- 4.345-8.055
- EPS
- -0.243
- Volume
- 1,310,871
- Market Cap
- 926.18M
- Dividend (Yield)
- N/A(N/A)
- Average Vol. (3m)
- 1,877,320
- P/E Ratio
- -20.77
- Beta
- 1.07
- 1-Year Change
- -15.37%
- Shares Outstanding
- 177,090,364
- Next Earnings Date
- Nov 03, 2022
What is your sentiment on Cerus?
or
Market is currently closed. Voting is open during market hours.
Cerus Corporation News
- 4 Biotech Stocks Wall Street Analysts Predict Will Gain More Than 60%
- ByStockNews-
The biotech industry has witnessed solid growth over the past year, in large measure attributable to the demand for drugs to fight COVID-19, among other diseases. The integration...
- Notable earnings after Thursday’s close
- BySeeking Alpha-
AAPL, ACIA, ACLS, AIRG, AIV, ALEX, AMH, ANET, AOSL, APPN, ARCB, ATGE, ATHN, ATR, ATRC, ATSG, BCOV, BFAM, BIO, BL, BLDR, BNFT, BRKR, BVX, CARB, CATM, CBPO, CBS, CC, CCRN, CECO,...
Cerus Corporation Analysis
- Single-Minded Market Snaps Weekly Winning Streaks
This week was all about the stimulus deal, so, since we still don’t have one, it makes complete sense that the market would move lower over these five days. It’s...
- Strong Retail Sales Bring Third Day of Gains
Stocks rose about 2% on Tuesday as three pieces of positive news helped the market to a third day of gains since last Thursday’s epic pullback. The biggest impact probably...
- 6 Stocks And Targets To Watch
1. Bloom Energy CorporationBloom Energy Corporation (NYSE:BE) popped on Wednesday and exploded for 1.87, or 22%, to 10.27, after reaching a session high of 10.50, on 9.6 million...
Cerus Corporation Company Profile
Cerus Corporation Company Profile
Cerus Corporation is a biomedical products company. It is focused on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, which is based on its technology for controlling biological replication, is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. Its INTERCEPT Blood System is intended for use with blood components and certain of their derivatives, such as plasma, platelets, red blood cells. Its product or product candidates under development includes INTERCEPT Blood System-Platelets, INTERCEPT Blood System-Plasma, INTERCEPT Blood System-Red Blood Cells and INTERCEPT Blood System-Cryoprecipitation. The INTERCEPT Blood System is designed to target and inactivate blood-borne pathogens, such as viruses, bacteria and parasites, as well as potentially harmful white blood cells, while preserving the therapeutic properties of platelet, plasma and red blood cell transfusion products.
Read More
Technical Summary
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Buy | Neutral | Sell | Strong Sell | Sell |
| Technical Indicators | Strong Buy | Strong Buy | Strong Sell | Strong Sell | Strong Sell |
| Summary | Strong Buy | Buy | Strong Sell | Strong Sell | Strong Sell |
Trending Stocks
Trending Stocks
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 308.08 | 308.49 | 301.30 | +7.89 | +2.63% | 2.30M | NYSE | |||
| 49.44 | 49.48 | 48.68 | +0.87 | +1.79% | 2.88M | NASDAQ | |||
| 8.37 | 8.47 | 8.16 | +0.24 | +2.95% | 6.64M | NYSE | |||
| 4.44 | 4.47 | 4.44 | 0.000 | 0.00% | 0.00 | NYSE | |||
| 32.74 | 32.75 | 31.69 | +0.89 | +2.81% | 4.93M | NYSE | |||
| 3.60 | 3.65 | 3.54 | +0.080 | +2.27% | 10.10M | NYSE | |||
| 1.085 | 1.10 | 1.01 | +0.0650 | +6.37% | 306.83K | NYSE | |||
| 1.205 | 1.23 | 1.19 | -0.0050 | -0.41% | 2.57M | NYSE | |||
| 46.26 | 46.28 | 45.16 | +1.36 | +3.03% | 1.89M | NYSE | |||
| 50.90 | 51.04 | 49.74 | -0.20 | -0.39% | 3.16M | NYSE | |||
| 43.51 | 43.66 | 43.24 | -0.11 | -0.25% | 5.55M | NYSE | |||
| 50.11 | 50.39 | 48.55 | +1.82 | +3.77% | 25.57M | NYSE | |||
| 0.0006 | 0.0006 | 0.0006 | 0.00000 | 0.00% | 0.00 | OTC Markets | |||
| 128.20 | 128.52 | 126.71 | +1.21 | +0.95% | 768.09K | NYSE | |||
| 183.19 | 183.33 | 171.07 | +13.45 | +7.93% | 967.46K | NYSE |
- Aug 26, 2020, 21:51Why the plunge yesterday on supposed good news? No mention of that anywhere.
- Aug 24, 2020, 18:22https://www.statnews.com/2020/08/23/fda-under-pressure-from-trump-expected-to-authorize-blood-plasma-as-covid-19-treatment/
- Feb 17, 2017, 21:14What's triggering the sudden rise?
- Jan 28, 2020, 17:39Think its the coronavirus scare, maybe testing
- Feb 17, 2020, 07:08Upcoming earnings on Feb 20